This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Transparency & HCP Engagement 2025
Delivered as a Hybrid Event August 12-14 2025
The Ritz-Carlton, Tysons CornerMcLean, VA

Emily Cunningham
Associate Director, Compliance at Ultragenyx Pharmaceutical Inc.
Speaker

Profile

Emily Cunningham is the Associate Director of Compliance at Ultragenyx Pharmaceutical Inc. In her current role, Emily has global responsibilities, including overseeing the auditing and monitoring program, transparency reporting, risk assessments, and driving the company’s data analytics and automation strategy. Prior to joining Ultragenyx, Emily spent over 10 years on the consulting side, providing strategic and operational support to a broad range of pre-commercial to large cap companies to address a variety of challenges. Her diverse experience and strategic insights help mitigate risk and drive compliance excellence at Ultragenyx.

Agenda Sessions

  • Explore Tailored Monitoring Strategies – Interactive Benchmarking by Company Size

    2:15pm